Document is current
Any future updates will be listed below
-
Authors
Jenny, Laura A.
Liu, Pei-Kang
Kolesnikova, Masha
Duong, Jimmy
Kim, Angela H.
Levi, Sarah R.
Greenstein, Vivienne C.
Tsang, Stephen H.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01EY09076)
National Institutes of Health (5P30CA013696)
National Institutes of Health (U01 EY030580)
National Institutes of Health (U54OD020351)
National Institutes of Health (R24EY028758)
National Institutes of Health (R24EY027285)
National Institutes of Health (5P30EY019007)
National Institutes of Health (R01EY018213)
National Institutes of Health (R01EY024698)
National Institutes of Health (R01EY026682)
National Institutes of Health (R21AG050437)
Schneeweiss Stem Cell Fund, New York State (SDHDOH01-C32590GG-3450000)
Foundation Fighting Blindness New York Regional Research Center Grant (TA-NMT-0116-0692-COLU)
Nancy & Kobi Karp
Crowley Family Funds
The Rosenbaum Family Foundation
Alcon Research Institute
Gebroe Family Foundation
Research to Prevent Blindness (RPB) Physician-Scientist Award
- License Information
-
More Information
Article History
Received: 1 February 2022
Accepted: 12 July 2022
First Online: 29 August 2022
Competing interests
: S.H. Tsang receives support from Abeona Therapeutics, Inc and Emendo. He is on the scientific advisory panel for Nanoscope Therapeutics and Medical Excellence Capital. He is also the founder of Rejuvitas.
